Kenny Marchant sold Globus Medical (NYSE: GMED)
Kenny Marchant (R-TX), a U.S. Representative, has disclosed 1 trade in Globus Medical (GMED) since 2015, a single sale, worth an estimated $8K in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts).
The trade highlighted here is a sale: Kenny Marchant sold $1,000 - $15,000 of Globus Medical (NYSE: GMED) on June 1, 2015. Since that trade, GMED is up +214.38% against the S&P 500 up +321.44%, an outperformance of -107.07%.
Data updated
Kenny Marchant's GMED trades vs the price
GMED is up +214.38% since Kenny Marchant sold on June 1, 2015, versus +321.44% for the S&P 500.
Performance since this trade
All Kenny Marchant GMED trades
Kenny Marchant & GMED trading FAQ
Is it legal for Kenny Marchant to trade Globus Medical (GMED) stock?
Yes. Members of Congress are allowed to trade individual stocks, including Globus Medical (GMED), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; this page does not imply the trade was improper.
When did Kenny Marchant sell GMED?
Kenny Marchant disclosed a sale of $1,000 - $15,000 of Globus Medical (GMED) on June 1, 2015, according to public STOCK Act filings.
How has GMED performed since Kenny Marchant's trade?
Since Kenny Marchant sold GMED on June 1, 2015, the stock is up +214.38%, versus +321.44% for the S&P 500 over the same period, an outperformance of -107.07%.
How soon must members of Congress disclose a trade?
Under the STOCK Act, members of Congress must publicly report a covered transaction within 45 days of the trade. Filings can still be delayed, amended, or contain errors.
Where can I see all congressional GMED trades?
Quantellect tracks every disclosed congressional trade in Globus Medical (GMED) on the Globus Medical congressional trading page, which aggregates filings across all members of Congress.
Kenny Marchant's GMED tradesAll congressional filings for Globus MedicalKenny Marchant's full profile
Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. Estimated prices and post-trade returns are derived algorithmically from public filings and end-of-day market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.